Livmarli 9.5 mg/mL oral solution Images
Generic Name: maralixibat
This medication has been identified as Livmarli 9.5 mg/mL oral solution. It is supplied by Mirum Pharmaceuticals Inc.
Livmarli is used in the treatment of Cholestatic Pruritus in Alagille Syndrome; Cholestatic Pruritus in Progressive Familial Intrahepatic Cholestasis and belongs to the drug class miscellaneous GI agents. Livmarli 9.5 mg/mL oral solution is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Livmarli
- Generic Name
- maralixibat
- Strength
- 9.5 mg/mL oral solution
- Availability
- Prescription only
- Drug Class
- Miscellaneous GI agents
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mirum Pharmaceuticals Inc.
- National Drug Code (NDC)
- 79378-0110
More about Livmarli (maralixibat)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous GI agents
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
